Myelosuppression such as extreme thrombocytopenia, neutropenia and anemia Normally reversible; may possibly control by dose interruption, dose reduction, or discontinuation of therapy Serious, accelerated or blast section CML with resistance or intolerance to prior therapy such as imatinib mesilate;[2] mg drug pre-dissolved in μL DMSO ( Learn liquid focus mg/mL, https://cornstalkt741jpv5.wikiannouncement.com/user